• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Lifeway Foods Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    11/12/25 9:00:42 AM ET
    $LWAY
    Packaged Foods
    Consumer Staples
    Get the next $LWAY alert in real time by email
    LIFEWAY FOODS, INC. 8-K
    false 0000814586 0000814586 2025-11-12 2025-11-12 0000814586 us-gaap:CommonStockMember 2025-11-12 2025-11-12 0000814586 LWAY:PreferredStockPurchaseRightsMember 2025-11-12 2025-11-12 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

     

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    FORM 8-K

    CURRENT REPORT

    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934


    Date of Report (Date of earliest event reported): November 12, 2025

     

    LIFEWAY FOODS, INC.

    (Exact Name of Registrant as Specified in Its Charter)

     

    Illinois 000-17363 36-3442829
    (State or Other Jurisdiction
    of Incorporation)
    (Commission
    File Number)
    (IRS Employer
    Identification No.)

     

    6431 Oakton Street Morton Grove, Illinois

    60053

    (Address of Principal Executive Offices) (Zip Code)
         

    Registrant’s telephone number, including area code: (847) 967-1010

     

    N/A

    (Former Name or Former Address, if Changed Since Last Report.)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ¨Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ¨Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ¨Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ¨Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered or to be registered pursuant to Section 12(b) of the Act:

     

    Title of each class   Trading Symbol(s)   Name of each exchange on which registered
    Common Stock   LWAY   Nasdaq Global Market
    Preferred Stock Purchase Rights   None   Nasdaq Global Market

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). ¨

     

    Emerging growth company ¨

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

     

     

     

     

     

       

     

     

    Item 2.02. Results of Operations and Financial Condition.

     

    On November 12, 2025, Lifeway Foods, Inc. (the “Company”) issued a press release announcing its financial results for the fiscal quarter ended September 30, 2025. A copy of this press release is furnished as Exhibit 99.1 to this report and is incorporated herein by reference.

     

    The information in this Item 2.02 of Form 8-K and Exhibit 99.1 attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, or incorporated by reference into any of the Company’s filings under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in any such filing regardless of any general incorporation language in such filing.

     

    Item 7.01. Regulation FD Disclosure.

     

    On September 30, 2025, the Company, entered into a Cooperation Agreement (the “Cooperation Agreement”) with Danone North America PBC, a Delaware public benefit corporation (“Danone”). Pursuant to the Cooperation Agreement, the Company filed a “shelf” registration statement of Form S-3 with the United States Securities and Exchange Commission (the “SEC”) on October 29, 2025, covering all shares of Company common stock beneficially owned by Danone and its affiliates. Under the Cooperation Agreement, the Company agreed to publicly disclose all information that was provided to Danone or its affiliates during the due diligence process relating to a potential transaction between Danone and the Company during the period between August 1, 2025 and September 17, 2025 that constitutes material nonpublic information, and in accordance with such obligation the Company is disclosing certain financial projections that were provided to Danone during such due diligence process.

     

    Background

     

    Although the Company has from time to time provided limited financial guidance to investors, the Company does not, as a matter of course, otherwise publicly disclose internal projections as to future performance, earnings or other results due to, among other reasons, the inherent difficulty of accurately predicting financial performance for future periods and the uncertainty, unpredictability and subjectivity of underlying assumptions and estimates.

     

    In connection with the exploration of a potential transaction with Danone, management prepared five-year financial projections at the direction of the Company’s board of directors (the “Board”). These projections were provided to Danone in August 2025 and are referred to in this Current Report on Form 8-K (this “report”) as the “Financial Projections.”

     

    The Financial Projections were not intended for public disclosure. Nonetheless, a summary of the Financial Projections is included below to provide the Company’s stockholders with access to information that was made available to Danone in August 2025.

     

     

     

     

     

     2 

     

     

    Summary of Financial Projections

     

    The following is a summary of the Financial Projections, with dollars in millions:

     

      2025E 2026E 2027E 2028E 2029E
    Net Sales $212 $252 $300 $353 $416
    Gross Profit $56 $65 $79 $100 $123
    Marketing Expenses $(10) $(12) $(13) $(15) $(17)
    Operating Income $18 $23 $33 $50 $69
    Adjusted EBITDA*(1) $29 $33 $46 $63 $83
    Capital Expenditures(2) $(26) $(18) $(12) $(4) $(3)
    Free Cash Flow*(3) $2 $12 $31 $56 $76

     

    (1)Adjusted EBITDA represents Operating Income, as reported, plus Depreciation and Amortization, plus Stock-Based Compensation, plus certain non-recurring expenses.
    (2)Capital Expenditures include amounts required for the previously announced expansion of the Company’s Waukesha facility.
    (3)Free Cash Flow represents Adjusted EBITDA less capital expenditures and change in working capital.
    *Non-GAAP financial measure. The Company does not provide a reconciliation of forward-looking non-GAAP financial measures where the Company believes such a reconciliation would imply a degree of precision and certainty that could be confusing to investors and the Company is unable to reasonably predict certain items contained in the GAAP measures without unreasonable efforts. This is due to the inherent difficulty of forecasting the timing or amount of various items that have not yet occurred and are out of the Company’s control or cannot be reasonably predicted. For the same reasons, the Company is unable to address the probable significance of the unavailable information. Forward-looking non-GAAP financial measures provided without the most directly comparable GAAP financial measures may vary materially from the corresponding GAAP financial measures.

     

    Important Information Regarding the Financial Projections

     

    The inclusion of the Financial Projections in this report does not constitute an admission or representation by the Company or any other person that the information is material. Moreover, the inclusion of the Financial Projections in this report should not be regarded as an indication that the Company or the Board or any other recipient of this information previously considered, or now considers, it to be an assurance of the achievement of future results or an accurate prediction of future results, and the Financial Projections should not be relied on as such.

     

    The Financial Projections are unaudited and were not prepared with a view toward public disclosure or compliance with the guidelines established by the American Institute of Certified Public Accountants for preparation and presentation of prospective financial information or United States generally accepted accounting principles (“GAAP”) or the published guidelines of the SEC regarding projections and the use of non-GAAP financial measures. Neither Grant Thornton LLP, the Company’s independent registered public accounting firm (“GT”), nor any other accounting firm, has compiled, examined or performed any procedures with respect to the Financial Projections, nor has GT expressed any opinion or any other form of assurance with respect to the Financial Projections or their achievability.

     

     

     

     3 

     

     

    The Financial Statements refer to Adjusted EBITDA and Free Cash Flow, which are non-GAAP financial measures. Please see the tables above for a description of how the Company defines Adjusted EBITDA and Free Cash Flow for purposes of the Financial Projections. Non-GAAP financial measures, including Adjusted EBITDA and Free Cash Flow, have limitations as analytical tools, and you should not consider any non-GAAP financial measure in isolation from or as a substitute for, or superior to, financial information prepared and presented in accordance with GAAP. Some of these limitations include the omission of certain material costs, such as depreciation and amortization, necessary to operate the Company’s business. Other companies, including companies in the Company’s industry, may calculate similarly titled non-GAAP financial measures differently, which reduces their usefulness as a comparative measure. You should consider the Company’s non-GAAP financial measures alongside other financial performance measures, including cash flow from operations, net income and the Company’s other GAAP results.

     

    The Financial Projections and the underlying assumptions upon which the Financial Projections were based are subjective in many respects and subject to multiple interpretations and frequent revisions attributable to the dynamics of the Company’s industry and are based on actual experience and business developments. Although presented with numerical specificity, the Financial Projections are forward-looking statements and reflect various estimates and assumptions, all of which are difficult to predict and subject to significant risks and uncertainties, many of which are beyond the Company’s control, including, among others, those described in the section below entitled “Forward-Looking Statements,” which could cause the Financial Projections or the underlying assumptions to be inaccurate and for actual results to differ materially from the Financial Projections. Accordingly, there can be no assurance that the projected results contemplated by the Financial Projections will be realized or that actual results will not differ materially from the results contemplated by the Financial Projections, and the Financial Projections cannot be considered a guarantee of future operating results and should not be relied upon as such. The Financial Projections also cover multiple fiscal years, and such information by its nature becomes less reliable with each successive year.

     

    Some or all of the assumptions that have been made in connection with the preparation of the Financial Projections may have changed since the dates on which the Financial Projections were prepared. Neither the Company nor any of its affiliates nor any of their respective officers, directors, advisors or other representatives has made or makes any representation to any stockholder of the Company or any other person or entity regarding the Financial Projections or the Company’s ultimate performance compared to the information contained in the Financial Projections or that the Financial Projections will be achieved. Economic and business environments can and do change quickly, which adds an additional significant level of uncertainty as to whether the results contemplated by the Financial Projections will be achieved. The Financial Projections have not been updated or revised to reflect information or results after the dates on which the Financial Projections were prepared or as of the date of this report, including the impact of exploring a potential transaction with Danone, the execution of the Cooperation Agreement or the effect of any business or strategic decisions or actions that may have been taken if the Company had not engaged with Danone with respect to a potential transaction, but that were instead altered, accelerated, postponed or not taken.

     

    Except as required by applicable law, neither the Company or any of its affiliates nor any other person intends to, and each of them disclaims any obligation to, update, revise or correct the Financial Projections to reflect circumstances existing or events occurring after the dates on which the Financial Projections were prepared or to reflect the existence of future circumstances or the occurrence of future events, even in the event that any or all of the assumptions underlying the Financial Projections are or become wrong or no longer appropriate. These considerations should be taken into account in reviewing the Financial Projections, which were prepared as of earlier dates.

     

    For the foregoing reasons, and considering that this report is being filed several months after the Financial Projections were prepared, as well as the uncertainties inherent in any forecasting information, stockholders and other persons are cautioned not to place unwarranted reliance on the Financial Projections. The Financial Projections should be evaluated, if at all, in conjunction with the historical financial statements and other information regarding the Company contained in the Company’s public filings with the SEC. The Company urges all of its stockholders to review its most recent SEC filings for a description of its reported financial results.

     

     

     4 

     

     

    Forward-Looking Statements

     

    This report contains “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995 regarding, among other things, unaudited estimated Net Sales, Gross Profit, Marketing Expenses, Operating Income, Adjusted EBITDA, Capital Expenditures and Free Cash Flow. These statements use words, and variations of words, such as “anticipate,” “plan,” “project,” “estimate,” “potential,” “forecast,” “will,” “continue,” “future,” “increase,” “believe,” “outlook,” “expect” and “predict.” You are cautioned not to rely on these forward-looking statements. These forward-looking statements are made as of the dates on which the Financial Projections were prepared or as of the date of this report, are based on expectations of future events as of such dates or date and are inherently subject to a number of risks and uncertainties, many of which involve factors or circumstances beyond the Company’s control. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, in each case after the dates on which the Financial Projections were prepared or the date of this report, actual results could vary materially from the Company’s expectations and projections. These risks, uncertainties and other factors include: price competition; the decisions of customers or consumers; the actions of competitors; changes in the pricing of commodities; the effects of government regulation; possible delays in the introduction of new products; and customer acceptance of products and services. A further list and description of these risks, uncertainties and other factors can be found in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024, as amended, which is available online at https://www.sec.gov or http://lifewaykefir.com/investor-relations/ or on request from the Company. The Company expressly disclaims any obligation to update any forward-looking statements (including, without limitation, to reflect changed assumptions, the occurrence of anticipated or unanticipated events or new information), except as required by law.

     

    Item 9.01. Financial Statements and Exhibits.

     

    (d) Exhibits:

     

    Exhibit No. Description
       
    99.1 Press Release dated November 12, 2025
       
    104 Cover Page Interactive Data File (embedded within the Inline XBRL document).

     

     

     

    5

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

        LIFEWAY FOODS, INC.  
           
           
    Date:  November 12, 2025   By: /s/ Julie Smolyansky  
          Name:

    Julie Smolyansky

     
          Title:

    Chief Executive Officer and Secretary

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     6 

     

    Get the next $LWAY alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $LWAY

    DatePrice TargetRatingAnalyst
    11/13/2025$35.00Buy
    The Benchmark Company
    9/24/2024Outperform → Market Perform
    Noble Capital Markets
    5/30/2024$20.00Market Perform → Outperform
    Noble Capital Markets
    4/5/2024$25.00Buy
    Lake Street
    3/27/2024Outperform → Market Perform
    Noble Capital Markets
    2/26/2024$14.00Market Perform → Outperform
    Noble Capital Markets
    11/27/2023Outperform → Market Perform
    Noble Capital Markets
    11/14/2023$13.00Market Perform → Outperform
    Noble Capital Markets
    More analyst ratings

    $LWAY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    The Benchmark Company initiated coverage on Lifeway Foods with a new price target

    The Benchmark Company initiated coverage of Lifeway Foods with a rating of Buy and set a new price target of $35.00

    11/13/25 9:14:26 AM ET
    $LWAY
    Packaged Foods
    Consumer Staples

    Lifeway Foods downgraded by Noble Capital Markets

    Noble Capital Markets downgraded Lifeway Foods from Outperform to Market Perform

    9/24/24 8:32:49 AM ET
    $LWAY
    Packaged Foods
    Consumer Staples

    Lifeway Foods upgraded by Noble Capital Markets with a new price target

    Noble Capital Markets upgraded Lifeway Foods from Market Perform to Outperform and set a new price target of $20.00

    5/30/24 9:15:56 AM ET
    $LWAY
    Packaged Foods
    Consumer Staples

    $LWAY
    SEC Filings

    View All

    SEC Form PREC14A filed by Lifeway Foods Inc.

    PREC14A - Lifeway Foods, Inc. (0000814586) (Subject)

    11/13/25 2:19:08 PM ET
    $LWAY
    Packaged Foods
    Consumer Staples

    SEC Form PRE 14A filed by Lifeway Foods Inc.

    PRE 14A - Lifeway Foods, Inc. (0000814586) (Filer)

    11/12/25 4:30:45 PM ET
    $LWAY
    Packaged Foods
    Consumer Staples

    SEC Form 10-Q filed by Lifeway Foods Inc.

    10-Q - Lifeway Foods, Inc. (0000814586) (Filer)

    11/12/25 9:01:02 AM ET
    $LWAY
    Packaged Foods
    Consumer Staples

    $LWAY
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Kefir-Leader Lifeway Foods Expands Farmer Cheese Distribution to 2,000 Walmart Stores Across the U.S.

    MORTON GROVE, Ill., Nov. 21, 2025 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ:LWAY), the leading U.S. supplier of kefir and fermented probiotic products that support the microbiome, today announced that its Farmer Cheese is now available in 2,000 Walmart stores nationwide. This milestone furthers the company's mission to make nutritious cultured dairy products rich in bioavailable protein more accessible to everyday shoppers. The distribution expansion reflects growing momentum and increased consumer demand in the cottage cheese and cultured dairy category, with consumers redi

    11/21/25 3:05:00 PM ET
    $LWAY
    $WMT
    Packaged Foods
    Consumer Staples
    Department/Specialty Retail Stores
    Consumer Discretionary

    Lifeway Foods Delivers Record Q3 2025 Net Sales and Strong Net Income Growth Continuing Kefir Category Dominance

    Achieves $57.1 million in net sales, a 29% volume-led net sales increase on a comparable basis, driven by the Company's flagship Lifeway Kefir Record-breaking quarter marks six years of uninterrupted quarterly net sales growth Significant gross margin expansion of 300 basis points and net income growth of 19% reflects the Company's disciplined operational execution MORTON GROVE, Ill., Nov. 12, 2025 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ:LWAY) ("Lifeway" or "the Company"), the leading U.S. supplier of kefir and fermented probiotic foods, today announced record financial results for the third quarter ended September 30, 2025.

    11/12/25 9:00:00 AM ET
    $LWAY
    Packaged Foods
    Consumer Staples

    Lifeway Foods and Drugstore Launch Limited-Edition Smoothie for November: Lifeway Probiotic Sunrise Smoothie

    MORTON GROVE, Ill., Nov. 11, 2025 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ:LWAY)("Lifeway" or "the Company"), the leading U.S. supplier of kefir and fermented probiotic products, has partnered with Drugstore, the all-day clean kitchen founded by award-winning chef and restaurateur Jeremy Fall, to launch the limited-edition Lifeway Probiotic Sunrise Smoothie. The Lifeway Probiotic Sunrise Smoothie brightens up autumn days with tropical flavors built on the powerhouse nutrition of Lifeway Kefir. Each sip blends lactose-free, protein-packed Lifeway Kefir with juicy pineapple,

    11/11/25 9:00:00 AM ET
    $LWAY
    Packaged Foods
    Consumer Staples

    $LWAY
    Leadership Updates

    Live Leadership Updates

    View All

    Leading Kefir Brand Lifeway Foods' CEO Julie Smolyansky Launches Industry Conversation to Explore New Voluntary Dairy Certification Standard

    Calls on Industry Partners to Join in Building a New Model for Public Health, Farmers,and Consumers MORTON GROVE, Ill., June 17, 2025 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ:LWAY), the leading U.S. supplier of kefir and fermented probiotic products, today announced that CEO Julie Smolyansky is launching an open industry-wide conversation to explore the creation of a new voluntary dairy certification standard. The proposal is designed to balance public health, consumer demand, and farmer viability — and to create a new model of trust and transparency in the dairy marketplace. The announcement is one of many initiatives coming from Lifeway Foods as part of their 40th anniversary plans and

    6/17/25 12:45:00 PM ET
    $LWAY
    Packaged Foods
    Consumer Staples

    $LWAY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Drori Rachel

    3 - Lifeway Foods, Inc. (0000814586) (Issuer)

    11/7/25 4:30:06 PM ET
    $LWAY
    Packaged Foods
    Consumer Staples

    Member of 10% owner group Smolyansky Ludmila sold $396,000 worth of shares (15,000 units at $26.40) (SEC Form 4)

    4 - Lifeway Foods, Inc. (0000814586) (Issuer)

    10/9/25 8:28:27 PM ET
    $LWAY
    Packaged Foods
    Consumer Staples

    Large owner Smolyansky Edward sold $2,166,926 worth of shares (83,643 units at $25.91), decreasing direct ownership by 7% to 1,151,642 units (SEC Form 4)

    4 - Lifeway Foods, Inc. (0000814586) (Issuer)

    10/3/25 4:34:30 PM ET
    $LWAY
    Packaged Foods
    Consumer Staples

    $LWAY
    Financials

    Live finance-specific insights

    View All

    Lifeway Foods Delivers Record Q3 2025 Net Sales and Strong Net Income Growth Continuing Kefir Category Dominance

    Achieves $57.1 million in net sales, a 29% volume-led net sales increase on a comparable basis, driven by the Company's flagship Lifeway Kefir Record-breaking quarter marks six years of uninterrupted quarterly net sales growth Significant gross margin expansion of 300 basis points and net income growth of 19% reflects the Company's disciplined operational execution MORTON GROVE, Ill., Nov. 12, 2025 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ:LWAY) ("Lifeway" or "the Company"), the leading U.S. supplier of kefir and fermented probiotic foods, today announced record financial results for the third quarter ended September 30, 2025.

    11/12/25 9:00:00 AM ET
    $LWAY
    Packaged Foods
    Consumer Staples

    Lifeway Foods® to Report Third Quarter 2025 Results on November 12, 2025

    MORTON GROVE, Ill., Nov. 5, 2025 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ:LWAY) ("Lifeway" or "the Company"), the leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, today announced it will report financial results for the third quarter ended September 30, 2025 on November 12, 2025 before market hours. A pre-recorded conference call and webcast with Julie Smolyanksy, Lifeway's President and Chief Executive Officer, discussing these results with additional comments and details will be made available through the "Investor Relations" sect

    11/5/25 12:45:00 PM ET
    $LWAY
    Packaged Foods
    Consumer Staples

    Lifeway Foods Delivers Record Q2 2025 Net Sales, Extends Kefir Category Leadership, and Estimates Over 20% Q3 Net Sales Growth to Date

    Kefir market leader posts $53.9 million in net sales, an 18% volume-led net sales increase on a comparable basis, marking nearly six years of uninterrupted net sales growth Company posts double-digit diluted EPS gains and strong gross margin expansion year-over-year Momentum accelerates into Q3 with highest weekly sales ever recorded in July and unaudited estimate of $26.4 million in net sales for the third quarter-to-date through August 11, up over 20% year-over-year MORTON GROVE, Ill., Aug. 12, 2025 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ:LWAY) ("Lifeway" or "the Company"), the leading U.S. supplier of kefir and fermented probiotic foods, today announced record financial results for th

    8/12/25 9:00:00 AM ET
    $LWAY
    Packaged Foods
    Consumer Staples

    $LWAY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Lifeway Foods Inc.

    SC 13D/A - Lifeway Foods, Inc. (0000814586) (Subject)

    11/15/24 4:33:49 PM ET
    $LWAY
    Packaged Foods
    Consumer Staples

    Amendment: SEC Form SC 13D/A filed by Lifeway Foods Inc.

    SC 13D/A - Lifeway Foods, Inc. (0000814586) (Subject)

    11/15/24 8:53:57 AM ET
    $LWAY
    Packaged Foods
    Consumer Staples

    Amendment: SEC Form SC 13D/A filed by Lifeway Foods Inc.

    SC 13D/A - Lifeway Foods, Inc. (0000814586) (Subject)

    9/23/24 4:07:26 PM ET
    $LWAY
    Packaged Foods
    Consumer Staples